About this webinar:
Pathologists are challenged to provide accurate and timely cancer diagnosis as the number of tests increases year-over-year.
Ibex uses artificial intelligence to develop clinical-grade solutions that extend beyond cancer detection and support pathologists with all clinically significant features, including cancer proportion and perineural invasion, helping them meet reporting needs.
In this webinar recording, Dr. Pantanowitz presents the results of a blinded clinical validation study of Ibex’s AI algorithm, performed on an external dataset of prostate biopsies analyzed by independent pathologists at the University of Pittsburgh Medical Center.